Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Fridman

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neurology|November 12, 2025
A Case for Disease-Specific Biomarkers for Rare Genetic DisordersVera Fridman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 9, 2021
Mechanisms and Treatments in Demyelinating CMTVera Fridman, Mario A Saporta
Neurology|July 11, 2014
The spectrum of axonopathies: from CMT2 to HSPVera Fridman, Sinéad M Murphy
Seminars in Neurology|October 28, 2015
Inherited NeuropathiesVera Fridman, M M Reilly
Neurology|November 25, 2024
Clinical Outcome Assessments and Biomarkers in Charcot-Marie-Tooth DiseaseBrett A McCray, Vera Fridman
Neurologic Clinics|February 25, 2012
Electrodiagnostic evaluation of lower extremity mononeuropathiesVera Fridman, William S David
Stroke|August 6, 2011
Graduating US neurology residents' experience with tissue-type plasminogen activator for acute stroke: a 10-year comparisonVera Fridman, Jonathan Raser, Kate Brizzi, et al.
Diabetologia|January 25, 2020
Diabetic neuropathy: what does the future hold?Brian C Callaghan, Gary Gallagher, Vera Fridman, et al.
Journal of the Peripheral Nervous System : JPNS|September 4, 2022
Adult-onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case reportEmily Forbes, Kaitlin Smith, Monica Petluru, et al.
Diabetologia|July 18, 2020
Diabetic neuropathy: the future is promising. Reply to Uusitupa M, Niskanen L, Laitinen T [letter] and Coppini DV [letter]Brian C Callaghan, Gary Gallagher, Vera Fridman, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neurology|November 12, 2025
A Case for Disease-Specific Biomarkers for Rare Genetic DisordersVera Fridman
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 9, 2021
Mechanisms and Treatments in Demyelinating CMTVera Fridman, Mario A Saporta
Neurology|July 11, 2014
The spectrum of axonopathies: from CMT2 to HSPVera Fridman, Sinéad M Murphy
Seminars in Neurology|October 28, 2015
Inherited NeuropathiesVera Fridman, M M Reilly
Neurology|November 25, 2024
Clinical Outcome Assessments and Biomarkers in Charcot-Marie-Tooth DiseaseBrett A McCray, Vera Fridman
Neurologic Clinics|February 25, 2012
Electrodiagnostic evaluation of lower extremity mononeuropathiesVera Fridman, William S David
Stroke|August 6, 2011
Graduating US neurology residents' experience with tissue-type plasminogen activator for acute stroke: a 10-year comparisonVera Fridman, Jonathan Raser, Kate Brizzi, et al.
Diabetologia|January 25, 2020
Diabetic neuropathy: what does the future hold?Brian C Callaghan, Gary Gallagher, Vera Fridman, et al.
Journal of the Peripheral Nervous System : JPNS|September 4, 2022
Adult-onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: A case reportEmily Forbes, Kaitlin Smith, Monica Petluru, et al.
Diabetologia|July 18, 2020
Diabetic neuropathy: the future is promising. Reply to Uusitupa M, Niskanen L, Laitinen T [letter] and Coppini DV [letter]Brian C Callaghan, Gary Gallagher, Vera Fridman, et al.
Pageof 3